← Back
$KRYS All transactions

Krystal Biotech, Inc.

M 10b5-1 Plan

$ Value

$0

Shares

7,500

Price

$0

Filed

Mar 3

Insider

Name

ROMANO KATHRYN

Title

Chief Accounting Officer

CIK

0001801385

Roles

Officer

Transaction Details

Transaction Date

2026-02-27

Code

M

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

26,068

Footnotes

15,000 performance stock units ("PSUs") were granted on February 29, 2024. Each PSU represented a contingent right to receive one share of the Company's common stock, subject to the achievement of certain performance criteria during the year ended December 31 2024, as approved by the Company's Compensation Committee, and the Reporting Person's continued service to the Company on each applicable vesting date following such achievement. The PSUs vested ratably over a two-year period. All of the performance criteria were achieved and the remaining one-half of the PSUs granted, or 7,500 PSUs, vested on February 27, 2026. | Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 7,500 RSUs on February 27, 2026. | The closing price on February 27, 2026 of the Company's common stock on the Nasdaq Global Select Market. | 2,200 restricted stock units ("RSUs") were granted on February 28, 2025. Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date. The RSUs vest ratably over a four-year period with the first installment, or 550 RSUs, vesting on February 27, 2026. | Represents the number of shares of common stock surrendered to the Company for tax withholding upon the vesting of 550 RSUs on February 27, 2026. | The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 6, 2025. The Rule 10b5-1 trading plan terminated upon completion of the sale of the shares of the Company's common stock reported on this Form 4, which represented the completion of all sales of the Company's common stock subject to the Rule 10b5-1 trading plan. | The stock options vest in four equal annual installments beginning on February 27, 2027. | Each RSU represents a contingent right to receive one share of the Company's common stock, subject to the Reporting Person's continued service to the Company on each applicable vesting date. | The number of RSUs in this column represents the number of shares of common stock the Reporting Person will receive assuming the Reporting Person's continued service to the Company on all applicable vesting dates. | The RSUs vest in four equal annual installments with the first installment vesting on February 27, 2027.

Filing Info

Accession No.

0001801385-26-000002

Form Type

4

Issuer CIK

0001711279

ROMANO KATHRYN's History

Date Ticker Type Value
2026-03-02 KRYS $201K
2026-02-27 KRYS M $0
2026-02-27 KRYS F $899K
2026-02-27 KRYS M $0
2026-02-27 KRYS F $66K
2026-02-27 KRYS M $0
2026-02-27 KRYS M $0
2026-02-27 KRYS A $0
2026-02-27 KRYS A $0
2026-02-09 KRYS M $794K

Other Insiders at KRYS (90d)

Insider Bought Sold Last
JANNEY DANIEL $19.4M 2026-02-27
ROSSI DINO A $5.0M 2026-02-19
Krishnan Krish S
President and CEO
$6.6M 2026-03-04
Krishnan Suma
President, R&D
$6.6M 2026-03-04
ROMANO KATHRYN
Chief Accounting Officer
$3.6M 2026-03-02